{"ModuleTitle": "Company Description", "CompanyName": "Myriad Genetics, Inc.", "Symbol": "MYGN", "Address": "320 WAKARA WAY, SALT LAKE CITY, Utah, 84108, United States of America", "Phone": "801-584-3600", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are one of the largest specialty molecular diagnostic laboratories in the\r\nworld and since our founding in 1992, have tested over 3.0 million patients. We\r\nare headquartered in Salt Lake City, Utah and generated worldwide revenues of\r\n$772.6 million during our fiscal year ended June 30, 2018. We are a leading\r\npersonalized medicine company acting as a trusted advisor to transform patient\r\nlives through pioneering molecular diagnostics. Through our proprietary\r\ntechnologies, we believe we are positioned to identify important disease genes,\r\nthe proteins they produce, and the biological pathways in which they are\r\ninvolved to better understand the genetic basis of human disease. We believe\r\nthat identifying these biomarkers (DNA, RNA and proteins) will enable us to\r\ndevelop novel molecular diagnostic tests that can provide important information\r\nto solve unmet medical needs.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2018%2f08%2f24%2f0001564590-18-022312.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Gary A. King", "title": "Executive Vice President-International Operations"}, {"name": "Jerry S. Lanchbury", "title": "Chief Scientific Officer"}, {"name": "R. Bryan Riggsbee", "title": "President, Chief Executive & Financial Officer"}, {"name": "Rishi Kacker", "title": "Chief Technology Officer"}, {"name": "Robert Gardner Harrison", "title": "Chief Information Officer"}], "Number_of_employees": ["2,600"], "Subsidiaries": ["NO INFO"]}